BTG deal consolidates UK biotech sector
BTG has agreed to buy Protherics for some £218 million, further consolidating the UK’s biotech sector. The deal will create Britain's largest biotech company, which is expected to enter the FTSE 250.
News
BTG has agreed to buy Protherics for some £218 million, further consolidating the UK’s biotech sector. The deal will create Britain's largest biotech company, which is expected to enter the FTSE 250.
News